Understanding the benefit of different eClinical systems is one thing. Making them work for you and your company is another.
The introduction of new eClinical technology and infrastructure has opened up huge opportunities for CROs and drug developers to make smarter, faster decisions during clinical trials. Maximizing the potential of these new systems and learning how to incorporate them into your business is key.
During the research for this meeting, a representative at Pfizer said to us:
"A lot of the challenges and opportunites are around process and an ability to actually use the tools that are in front of us today. How do we really scale and leverage those tools with our organization?" Pzifer
It's a critical question. More than that, it's definitely not unique to Pzifer.That's why eClinical Intelligence has specifically sought out companies that are innovating in the field, overcoming the challenges and converting the opportunities. Companies including AstraZeneca, Bristol Myers Squibb, Roche, J&J, Genentech and Biogen Idec are bringing their solutions to the table to benefit CROs and drug developers alike, discussing how to increase clinical trial efficiency and get drugs into the market faster.
Whether you are a CRO or drug developer, making better, smarter decisions about your clinical trials is paramount to maximizing the results they deliver.
eClinical Intelligence offers an unmissable opportunity to attend a focussed, collaborative gathering of CROs and drug developers. To ask questions. To understand. To discuss. All with the aim of connecting a community on the cusp of revolutionising the use of eClinical systems. It’s about moving beyond why and what, and focussing on how you can leverage and scale new technologies and initiatives within your organization.
Expect to leave the meeting with at least a dozen new ideas and approaches that you can implement in your organization immediately on your return. Ideas on how you can optimize eClinical technologies to make a tangible difference to the performance of your team, your department, and your business.
eClinical Intelligence will present 15 different case studies delivered by Roche, Genentech, Pfizer, BMS, Amgen, Janssen and other drug developers: supported by contributions from patient advocacy groups, consortiums and other clinical organizations. All focused on how CROs and drug developers can make better use of eClinical data to make better clinical decisions. That means more effective data capture and data management, improved patient safety and reduced time to market.
Take home practical advice. Benefit from smaller groups sessions and in-depth discussions where you can address your specific issues. Use the knowledge of your peers to get to the best solution quickly.
Discovering MDR: An in-depth look at the technologies that make a metadata registry successful: This workshop will look at the technologies that make metadata registries successful. Presented with examples of design structure you will learn how data standards are stored and accessed. Learn how to get most out of an MDR.
What no-one tells you about standards: structures and processes for optimal standards implementation: Understanding the processes and structures that can be implemented to help you get the most out of your standards investment.
If you are struggling with the current inefficiencies of technology in your clinical trial and are searching for new ways to streamline your process then this conference is for you.
Book your place now if you work in:
Search 'eClinical Decision Making'